Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer

被引:1
|
作者
Cheng-Xue Dang
Yue Han
Zhao-Yin Qin
Ya-Jun Wang From the Department of Tumor Surgery
机构
关键词
pancreatic cancer; p21ras; p53; PCNA; immunohistochemistry;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
Objective: To study the clinical significance and effectof p21, p53 protein as well as proliferating cell nuc-lear antigen (PCNA) on the occurrence and develop-ment of pancreatic carcinoma.Method: p21, p53 protein and PCNA expressionswere detected in specimens from 30 patients withpancreatic carcinoma and 3 samples of normal pan-creatic tissue by immunohistochemistry. The datawere analyzed together with clinical findings.Results: The positive expression rates of p21 and p53proteins were 75.0% and 57.3% respectively in pan-creatic carcinoma, which were significantly differentfrom those in the normal tissue (P<0.05). p21 andp53 proteins were positively correlated (P<0.05).The positive expression of PCNA was 43.33%±17.99%, that was significantly higher than that inthe normal pancreatic tissue (P<0.05). The expres-sion of PCNA was correlated with the histologicalgrade (P<0.05). The positive expression rate wasconsistent with the exacerbation of cancer. The ex-pression was also correlated significantly with prog-nosis and p53 expression (P<0.05).Conclusions: The occurrence and development ofpancreatic cancer are the result of associated functionfor many oncogenes and antioncogenes. PCNA maybe helpful to identify malignant degree and prognosisof pancreatic cancer.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 50 条
  • [1] The expression of proliferating cell nuclear antigen, p53, p21, and apoptosis in primary gastric lymphoma
    Aoyagi, K
    Kohfuji, K
    Yano, S
    Murakami, N
    Miyagi, M
    Takeda, J
    Shirouzu, K
    SURGERY, 2002, 132 (01) : 20 - 26
  • [2] Role of p21, p53, and proliferating cell nuclear antigen in growth regulation by nitric oxide
    Feng, JW
    Chou, MF
    Shelat, HS
    Zoldhelyi, P
    CIRCULATION, 1998, 98 (17) : 183 - 183
  • [3] A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse
    Naresh, KN
    OConor, GT
    Soman, CS
    Johnson, J
    Advani, SH
    MaGrath, IT
    Bhatia, KG
    HUMAN PATHOLOGY, 1997, 28 (05) : 549 - 555
  • [4] The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer
    Chien, CY
    Huang, CC
    Cheng, JT
    Chen, CM
    Hwang, CF
    Su, CY
    CANCER LETTERS, 2003, 201 (02) : 217 - 223
  • [5] P53, p21 and Bcl-2 proteins expression and clinical significance in papillary thyroid carcinoma
    Chung, S.
    Jung, T.
    Chung, J.
    Jung, J.
    Oh, Y.
    Kim, K. -S.
    Shin, H.
    HORMONE RESEARCH, 2007, 68 : 22 - 22
  • [6] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [7] Immunohistochemical expression of cell proliferating nuclear antigen (PCNA) and p53 protein in cervical cancer
    Madhumati G.
    Kavita S.
    Anju M.
    Uma S.
    Raj M.
    The Journal of Obstetrics and Gynecology of India, 2012, 62 (5) : 557 - 561
  • [8] The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma
    Dergham, ST
    Dugan, MC
    Joshi, US
    Chen, YC
    Du, W
    Smith, DW
    Arlauskas, P
    Crissman, JD
    Vaitkevicius, VK
    Sarkar, FH
    CANCER, 1997, 80 (03) : 372 - 381
  • [9] Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer
    Setala, L
    Kosma, VM
    Lipponen, P
    Naukkarinen, A
    Nordling, S
    Hollmen, S
    Eskelinen, M
    Syrjanen, K
    Alhava, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (09) : 497 - 502
  • [10] Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer
    Leena Setälä
    Veli-Matti Kosma
    Pertti Lipponen
    Anita Naukkarinen
    Stig Nordling
    Sinikka Hollmén
    Matti Eskelinen
    Kari Syrjänen
    Esko Alhava
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 497 - 502